| Name | Title | Contact Details |
|---|
Northern Michigan Regional Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Northern Michigan Regional Hospital is based in Petoskey, MI. You can find more information on Northern Michigan Regional Hospital at www.northernhealth.org
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.
Predictive Physiology and Medicine (PPM) is a Bloomington, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The University of Miami Health System delivers leading-edge patient care by the region`s best doctors, powered by the groundbreaking research of the University of Miami Leonard M. Miller School of Medicine. As South Florida`s only university-based medical system, UHealth is a vital component of the community that is leading the next generation of health care.
Decade of Discovery is a major research initiative led by the Minnesota Partnership for Biotechnology and Medical Genomics focused on preventing, optimally treating and ultimately curing diabetes.